Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.

D Milojkovic, NCP Cross, S Ali, J Byrne, G Campbell, FL Dignan, M Drummond, B Huntly, S Marshall, MF McMullin, P Neelakantan, M Raghavan, AJ Mead

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)62-74
JournalBritish Journal of Haematology
Issue number1
Publication statusPublished - May 2020

Cite this